Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Radiotherapy of Intraocular and Orbital Tumors
Since the publication of the first edition of Radiotherapy of Intraocular and Orbital Tumors in 1993 the treatment programs for cure have changed from the dominance of surgical resection to the utilization of radiation therapy with preservation of the eye intact and preservation of vision. In 2002 about 2,300 primary eye tumors will be diagnosed in the United states, 75% of which will be choroidal melanomas, 20% retinoblastomas, and the remainder a wide variety of tumors - malignant lymphoma, rhabdomyosarcomas, liposarcomas, meningiomas, malignant fibrous histiocytomas, etc. Even so, the majority of malignant tumors of the eye are metastatic, primarily from cancers of the lung or breast. The...
Cancer, Radiation Therapy, and the Market
Cancer, Radiation Therapy, and the Market shows how the radiation therapy specialty in the United States (later called radiation oncology) co-evolved with its device industry throughout the twentieth-century. Academic engineers and physicians acquired financing to develop increasingly powerful radiation devices, initiated companies to manufacture the devices competitively and designed hospital and freestanding procedure units to utilize them. In the process they incorporated market strategies into medical organization and practice. This provocative inquiry concludes that public health policy needs to re-evaluate market-driven high-tech medicine and build evidence-based health care systems.
Radiotherapy of Intraocular and Orbital Tumors
Radiotherapy of Intraocular and Orbital Tumors presents a new approach to the role of radiation therapy in the management of ophthalmic cancer. The indications for ultrasonography, computed tomography, and magnetic resonance imaging studies are analyzed, and treatment techniques, together with their results, are described for each tumor. Particle beam and plaque irradiation are reviewed, and conservative and surgical management of radiation effects are detailed. In the past, most books on this subject included a chapter on radiotherapy but emphasized the dangers of radiation complications. However, great progress in understanding the effects of irradiation upon the tissues of the eye and orb...
Practical Approaches to Cancer Invasion and Metastases
In the United States in 1993 the American Cancer Society estimated that there were about 1,300,000 new cases of invasive cancer diagnosed. At the time of presentation about 70% of those patients represented limited local regional disease without evidences of distant dissemination. About 30% of the patients had demonstrated metastatic disease at the time of initial diagnosis or about 390,000 patients. Of those patients with local regional disease about 56% would be cured by the best treatment programs including surgery, radiation therapy with or without chemotherapy when given for cure. Therefore, of the 1,300,000 new cases of invasive cancer, about 509,000 would be cured by the best treatmen...
Age-Related Macular Degeneration
Age-related macular degeneration (ARMD) is a frequent disease of the elderly and the most common cause of blindness. Recently, various new treatment options have become available for ARMD. This book, written by recognized experts and including the results of international study groups, provides a comprehensive report on these treatments, documenting their rationale, uses, side-effects, and benefits. It will be of immense value to all with an interest in ARMD.
The Radiation Therapy of Benign Disease
This volume discusses radiotherapy and its role in the treatment of benign diseases. Its intent is to broaden the application of radiotherapy beyond malignancy to treat a range of clinical concerns, from minor skin problems to life-threatening arterial disease. In addition, it aims to encourage medical practitioners to consider the benefits versus the risks of radiotherapy, and assess the most modern technology for uses that may benefit the greatest number of patients.
